Research Studies
Back to Results
VA Protocol: Reducing Hippocampal Hyperactivity and Improving Cognition in Schizophrenia
Description
Adults diagnosed with schizophrenia are needed for a clinical trial to learn more about how a new medication may affect the brain. Study participants will complete MRI scans, clinical interviews, and cognitive tests. Duration of participation: 14 weeks. Participants will be compensated for their time.
MoreDetails
Age
Adult
Eligibility
Volunteers must have a diagnosis of schizophrenia or schizoaffective disorder.
Volunteers must be between 18-70 years old, have a diagnosis of schizophrenia or schizoaffective disorder, not have metal or electronic devices in their body and not be claustrophobic.
Type of Study
Treatment
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
Jason Tregellas, PhD
Study ID
Protocol Number: 16-1831
More information available at ClinicalTrials.gov: NCT03034356
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers